The availability of the pure recombinant molecules provides the opportunity to formulate preparations that are free from the non-allergenic ballast proteins present in natural allergen extracts and which contain relative concentrations of the allergens in clinically appropriate proportions.
An important study formulated innovative preparation such as THERACURMIN and confirmed that its oral bioavailability is approximately 30-times higher than curcumin powder in both rats and humans and results also show that THERACURMIN enhanced gastrointestinal absorption as a result of colloidal dispersion [ 187].
The present trial compared the safety and immunogenicity of PfCS102 synthetic peptide 282-383 itsits GMP preparation formulated in three doses with Montanide ISA 720 or AS02A.
L-BLP25 is a lyophilized preparation, formulated to contain 241 μg of BLP25 lipopeptide and 128 μg of immunoadjuvant monophosphoryl lipid A in a 5 mL glass vial.
The first preparation, formulated according to the process described by Schwarz et al 20 (the same method as that used in the production of Tissucol) had a higher ratio of clottable to total protein than did the second, which was formulated according to the method described by Martinowitz and Bal 21 (used in the production of Quixil), but at a much lower fibronectin to fibrinogen ratio.
The prepared SLN were formulated into a gel preparation, using carbopol 940.
A combination of benefits is now available from a wide range of preparations formulated and marketed as sports drinks and featuring widely in beverage markets world-wide.
The immunogenicity of the SAM (H1/LNP) vaccine candidate was compared to that of A/California/07/2009-like (X-179A reassortant) influenza subunit vaccine preparations formulated with or without the MF59 oil-in-water emulsion adjuvant in mice.
The safety and patient acceptance of two preparations of modified (reduced and alkylated) immune globulin for intravenous use were evaluated; one preparation was formulated as a 5% solution in 10% maltose (IGIV-maltose), the other did not contain maltose (IGIV).
To report the successful use of topical cysteamine formulated from the oral preparation in the treatment of severe photophobia from corneal crystal deposition in cystinosis.
A traditional Chinese medicine (TCM) preparation was formulated from orange peel (Pericarpium Citri Reticulatae), hawthorn (Crataegus pinnatifida), astragalus (Astragalus membranaceus (Fisch).
